Androstenediol dipropionate
Appearance
(Redirected from Androst-5-ene-3β,17β-diol 3β,17β-dipropionate)
![]() | |
![]() | |
Clinical data | |
---|---|
Trade names | Bisexovis, Bisexovister, Ginandrin, Stenandiol |
Other names | 5-Androstenediol 3β,17β-dipropionate; Androst-5-ene-3β,17β-diol 3β,17β-dipropionate |
Routes of administration | Intramuscular injection |
Drug class | Androgen; Anabolic steroid; Androgen ester |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.017.222 |
Chemical and physical data | |
Formula | C25H38O4 |
Molar mass | 402.575 g·mol−1 |
3D model (JSmol) | |
| |
|
Androstenediol dipropionate (brand names Bisexovis, Bisexovister, Ginandrin, Stenandiol), or 5-androstenediol 3β,17β-dipropionate, also known as androst-5-ene-3β,17β-diol 3β,17β-dipropionate, is a synthetic anabolic–androgenic steroid and an androgen ester – specifically, the dipropionate diester of 5-androstenediol (androst-5-ene-3β,17β-diol) – which has been marketed in Europe, including in Spain, Italy, and Austria.[1][2][3][4][5]
See also
[edit]References
[edit]- ^ Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 86–. ISBN 978-1-4757-2085-3.
- ^ Index Nominum 2000: International Drug Directory. Taylor & Francis. January 2000. pp. 64–. ISBN 978-3-88763-075-1.
- ^ Morton IK, Hall JM (6 December 2012). Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Science & Business Media. pp. 18–. ISBN 978-94-011-4439-1.
- ^ Negwer M, Scharnow HG (4 October 2001). Organic-chemical drugs and their synonyms: (an international survey). Wiley-VCH. p. 2653. ISBN 978-3-527-30247-5.
- ^ Hyde TE, Gengenbach MS (2007). Conservative Management of Sports Injuries. Jones & Bartlett Learning. pp. 1100–. ISBN 978-0-7637-3252-3.